SHANGHAI - Swiss pharmaceutical giant Roche has announced plans to invest 2.04 billion yuan ($283 million) in building a new ...

Even as Roche makes a major investment pledge across its U.S. business, the Swiss pharmaceutical giant isn’t neglecting its ...

Switzerland will once again Friday try to talk its way out of punitive tariffs on its exports to the United States, which ...

The Swiss Biotech Report 2025 has indicated that R&D investment in Switzerland increased in 2024, compared to 2023.

Basel will be in the international spotlight for a week of festivities surrounding the Eurovision Song Contest but the Swiss ...

With growing uncertainty in the US, Chinese companies are swooping in to present themselves as stable, open partners to the ...

Roche revealed in its first-quarter results statement ... oral selective oestrogen receptor degrader (SERD) class. The Swiss pharma said in its update that the acelERA trial comparing giredestrant ...

Spark already has a gene therapy for a rare form of inherited blindness Luxturna approved in the US, although Roche’s Swiss rival Novartis owns rights in Europe, where the drug is also approved.

(Reuters) -Swiss drugmaker Roche is petitioning the U.S. government in direct talks for import tariff exemptions, arguing the products it ships into the United States are offset by its exports of ...